Keyword Suggestion
Domain Informations
Synoxtherapeutics.com lookup results from whois.123-reg.co.uk server:
- Domain created: 2020-10-12T10:10:46Z
- Domain updated: 2024-10-02T18:07:17Z
- Domain expires: 2027-10-12T10:10:46Z 1 Year, 271 Days left
- Website age: 5 Years, 92 Days
- Registrar Domain ID: 2565304536_DOMAIN_COM-VRSN
- Registrar Url: http://www.meshdigital.com
- Registrar WHOIS Server: whois.123-reg.co.uk
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.3454502310
- Name server:
- LIZ.NS.CLOUDFLARE.COM
- NASH.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.21.91.8
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.21.91.8)
Spam Check (IP: 104.21.91.8)
Recent Searched Sites
› Lag.uia.mx (5 seconds ago) / MX
› Fivejes.com (8 seconds ago) / US
› Aluno.contabilistaplay.com.br (1 seconds ago) / US
› 192.166.47.116 (3 seconds ago) / GB
› Maishidc.com (2 seconds ago) / US
› Gvtg.ch (9 seconds ago) / CH
› Kanekoh.web.fc2.com (1 seconds ago) / US
› Mysitl.com (2 seconds ago) / IE
› Westernreservelacesociety.co (2 seconds ago) / US
› Bsvtrust.com (2 seconds ago) / ZA
› Sinel-st.ru (3 seconds ago) / RU
› Dijk92.be (9 seconds ago) / BE
› Mariyatoursandtravels.com (2 seconds ago) / US
› Beastroll.org (11 seconds ago) / US
› Synoxtherapeutics.com (1 seconds ago) / US
› Hnanavet.com (4 seconds ago) / DE
› Viacom.helpshift.com (9 seconds ago) / US
› Loginet.ru (2 seconds ago) / RU
› Mishima.roukyou.gr.jp (6 seconds ago) / JP
› Zsz.ru (2 seconds ago) / RU
Websites Listing
We found Websites Listing below when search with synoxtherapeutics.com on Search Engine
SynOx Therapeutics - Home
SynOx Therapeutics was founded in Nov 2020 and is focused on developing emactuzumab for the... 7/8 Wilton Terrace, Dublin, Ireland D02 KC57
Facebook.comSynOx Therapeutics | LinkedIn
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx ...
Linkedin.comSynOx Therapeutics - Contacts, Employees, Board …
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Crunchbase.comCuring genetic heart diseases | Phlox Therapeutics
Phlox Therapeutics pioneers gene therapy to alleviate and cure different heart diseases. By embracing new ideas, we want to change the world for …
Phloxtherapeutics.comTherapeutic Differentiation Strategies | Differentiated …
AUTODX. Our Automatic Differentiation (AutoDX) platform consists of a suite of tools that enable differentiable portfolio planning by screening our proprietary Differentiated Therapeutic Knowledge Graph (DTKG) to identify protein degradation strategies for targets with indications of high unmet need. AutoDX significantly reduces time reviewing ...
Dxtherapeutics.comSynOx Therapeutics - Crunchbase Company Profile & Funding
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
Crunchbase.comSynOx Therapeutics Ltd. - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …
Profiles.biocentury.comSynOx Therapeutics | CipherBio
SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of new and innovative therapies to …
Cipherbio.comSYNOX THERAPEUTICS UK LIMITED · John Eccles House, Robert …
2021-04-07 · SYNOX THERAPEUTICS UK LIMITED (company# 13318557) is a company registered with Companies House, United Kingdom. The incorporation date is April 7, 2021. The company status is Active. The address is John Eccles …
Opengovuk.comSynOx Therapeutics | EU-Startups
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland ...
Eu-startups.comSynOx Therapeutics Further Strengthens Team With Appointments …
2021-08-03 · SynOx Therapeutics Limited is a Dublin, Ireland Advanced clinical biopharmaceutical company developing emactuzumab, a first-order monoclonal antibody against CSF-1R, for the treatment of tenosynovial giant cell tumors (TGCT) and other macrophage disorders. SynOx is led by an experienced team of industry professionals with successful …
Oltnews.comSYNOX THERAPEUTICS UK LIMITED - GetTheData
SYNOX THERAPEUTICS UK LIMITED is an active private limited company, incorporated on 7 April 2021. The nature of the business is Research and experimental development on biotechnology. The company's registered office is on Robert Robinson Avenue, Oxford. The company's next accounts are due on 30 September 2022, and fall under the accounts …
Getthedata.comSynOx Therapeutics Company Profile: Valuation & Investors
2020-11-11 · SynOx Therapeutics General Information. Description. Developer of humanized monoclonal antibodies intended to improve the lives of patients with tenosynovial giant cell tumors. The company's antibody targets and depletes macrophages in the tumor tissue, enabling patients with the treatment of diffuse tenosynovial giant cell tumors and other ...
Pitchbook.comSynOx Therapeutics | TechIreland
TechIreland connects you to the people and companies leading Irish innovation globally.
Techireland.orgSynOx Therapeutics | CipherBio
Explore SynOx Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!
Cipherbio.comIx Therapeutics
Ix Therapeutics is a biotech company in the field of oncology focusing on the development of functional antibodies based on novel and proprietary targets. Founded by Indivumed in 2021 and funded by Xlife Sciences, the joint venture strives to thereby support biopharmaceutical companies in the subsequent clinical development of medical products.
Ix-therapeutics.comSynOx Therapeutics - Posts | Facebook
SynOx Therapeutics was founded in Nov 2020 and is focused on developing emactuzumab for the... 7/8 Wilton Terrace, Dublin, Ireland D02 KC57
Facebook.comSynOx Therapeutics Strengthens Team with appointment of Ton …
2021-07-27 · Dublin, Ireland, July 27, 2021: SynOx Therapeutics Limited (“SynOx” or the “Company”), the late-stage clinical biopharmaceutical company developing emactuzumab for the treatment of Tenosynovial Giant Cell Tumours (TGCT), today announces the appointment of a new Chairman and Chief Executive Officer and plans for a registrational trial of emactuzumab …
Optimumcomms.comSynOx Therapeutics - Overview, News & Competitors
View SynOx Therapeutics (synoxtherapeutics.com) location in Ireland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.
Zoominfo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| blackdownhillsdogpark.com | tucows.com | -3 Years, -67 Days |
| geospike.com | tucows.com | 5 Years, 125 Days |
| pollaksala.com | joker.com | -3 Years, -46 Days |
| drgadol.com | fastdomain.com | -3 Years, -35 Days |
| netsurbible.com | gmo.jp | -3 Years, -153 Days |
| zapbg.com | godaddy.com | -3 Years, -290 Days |
| cartlyapp.com | infomaniak.com | -3 Years, -117 Days |
| lurex.com | eurodns.com | -2 Years, -136 Days |
| newcity.co | whois.godaddy.com | -3 Years, -53 Days |
| wplab.com | hetzner.com | -3 Years, -237 Days |